SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
SEC Accession No. 0001193125-11-262745
Filing Date
2011-10-03
Accepted
2011-10-03 16:44:51
Documents
3
Filing Date Changed
2011-10-03
Effectiveness Date
2011-10-03

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d237724d8k.htm DEFA14A 30147
2 AGREEMENT AND PLAN OF MERGER d237724dex21.htm EX-2.1 495095
3 PRESS RELEASE d237724dex991.htm EX-99.1 18538
  Complete submission text file 0001193125-11-262745.txt   544798
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-27570 | Film No.: 111120708
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1